AJOVY is the only anti-CGRP treatment for the prevention of migraine with quarterly (225 mg x 3) and monthly (225 mg) dosing options.1
Continue to Efficacy page of AJOVY

AJOVY helped significantly reduce monthly migraine days vs placebo1

See the clinical trial data for AJOVY
Continue to Dosing flexibility page of AJOVY

Flexibility to help you meet your patients' needs1

dosing options for ajovy
Continue to Safety page of AJOVY

Safety profile in clinical trials for AJOVY1

safety profile for ajovy

Support for you and your patients

Continue to Savings Offer of AJOVY
Patients pay as little as #{offerValue}# for AJOVY*

Your commercially insured patients can use this offer and save on AJOVY. 
*Eligibility and restrictions apply.

Savings Offer
Continue to Cover My Meds
Insurance coverage support

Quickly access and submit a health plan–specific prior authorization form for AJOVY.

Get Started
Administering AJOVY

AJOVY may be administered by healthcare professionals in the office, or at home by patients and/or caregivers.

administering AJOVY
CGRP: calcitonin gene-related peptide.